Molecular Research and Treatment in Multiple Sclerosis
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 25 September 2024 | Viewed by 98
Special Issue Editors
Interests: human genetics; neurodegenerative diseases; multiple sclerosis; cytogenetics
Interests: public health genomics; genomic medicine in health systems; mechanisms of human genetic and complex disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system with autoimmune and inflammatory features. The precise etiology of MS remains elusive, presumed to result from complex interactions between genetic predispositions and environmental influences, infectious exposures, and factors that lead to pro-inflammatory conditions and neuronal injury. Despite extensive research on the development of new drugs, there is no effective therapy for all patients, and the response of patients to available medication varies greatly.
This Special Issue aims to expand knowledge and clarify the molecular mechanisms and genetic factors involved in multiple sclerosis in order to search for accurate biomarkers and contribute to advances in the treatment of all forms of MS.
This Special Issue only considers papers that use molecular data to improve our understanding of the genetic and molecular basis of the disease and to develop therapeutic strategies based on the underlying mechanisms of MS, neuroprotection, and repair.
Therefore, we invite researchers and clinicians to submit articles with their findings that address various aspects of MS, with a focus on molecular research and treatment strategies.
Dr. Nada Starčević Čizmarević
Dr. Borut Peterlin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple sclerosis
- neuroinflammation
- neurodegeneration
- genetics
- molecular research
- biomarkers
- neuroimaging
- therapy
